drugset / Trial / NCT02641899
Study of the Effects of ITCA 650 on Gastric Emptying and Interaction of ITCA 650 on 4 Commonly Studied Drugs
NaSingle-groupOpen-labelOther
Summary
A Phase 1, Fixed-Sequence, Open-label Study in Healthy Subjects to Estimate the Effects of ITCA 650 on Gastric Emptying and on the Absorption Pharmacokinetics of Each of 4 Commonly Studied DDI Probe Compounds.
Timeline
- Start
- 2015-12
- Primary completion
- 2016-03
- Completion
- 2016-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Acetaminophen | Small molecule | 1000 mg | Oral |
| Subject | Atorvastatin | Small molecule | 40 mg | Oral |
| Subject | Digoxin | Other / unclassified | 0.5 mg | Oral |
| Subject | Exenatide | Peptide | 60 ug | — |
| Subject | LISINOPRIL ANHYDROUS | Small molecule | 20 mg | Oral |
| Subject | Warfarin | Small molecule | 25 mg | Oral |
Indications
No indication recorded.